MentionFox
Home › funding signals › Angiex, Inc.
Company · SEC filings

Angiex, Inc. funding history

Angiex, Inc. has 2 Form D filings on record, from 2025-08-14 to 2025-09-26. Together its new offerings report $10.98M sold.

Pitching, partnering or investing alongside them? See who really runs and owns Angiex, Inc.

Free to see. No signup.

In its own words: “Angiex is developing first-in-class Nuclear-Delivered Antibody-Drug Conjugates™ (ND-ADCs) to address the hallmarks of cancer lethality.” (angiex.com, checked November 8, 2026)

Is this your company?

Funding historyFounders and team

Is Angiex, Inc. a real, registered company?

Angiex, Inc. is a registered filer with the SEC (CIK 1710380) and has filed since 2025-08-14. 2 filings are on record, the latest on 2025-09-26.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

How much has Angiex, Inc. raised?

Its new offerings report $10.98M sold across 1 offering, as its own filings state.

Run the free check on Angiex, Inc. →

Based
CAMBRIDGE, MASSACHUSETTS
Industry group
Biotechnology
Filings
2
Raised (new offerings)
$10.98M

Every filing

FiledTypeAmount soldTotal offeringRecords
2025-09-26Amendment
first sale 2025-07-31
$21.99M$28.41MSEC filing
2025-08-14New offering
first sale 2025-07-31
$10.98M$20.28MSEC filing

Keep reading

More on Angiex, Inc. and the records around it.

The people at Angiex, Inc.

Angiex, Inc. elsewhere on the record

What do you want to do with Angiex, Inc.?

Want the whole picture on Angiex, Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Angiex, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Angiex, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    4 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from Angiex, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Filings & events

Fundraising filings

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Angiex, Inc.. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/company/angiex-inc
Last updated 2026-09-26
Primary record: SEC filing 1 · SEC filing 2
Angiex, Inc. funding history: 2 SEC filings, $10.98M raised. MentionFox, 2026-09-26. https://mentionfox.com/company/angiex-inc